Macleods Pharmaceuticals SA Pharmaceutical Import Profile — South Africa (DGFT 2022–2026)

Name: Macleods Pharmaceuticals SA Pharmaceutical Import Records from India — 7 Products, $11.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Macleods Pharmaceuticals SA — Pharmaceutical Importer Profile (2026) | 7 Products, $11.1M Trade | TransData Nexus

Macleods Pharmaceuticals SA

Pharmaceutical Importer · South Africa · Advanced Antibiotics Focus · $11.1M Total Trade · DGFT Verified

Macleods Pharmaceuticals SA is a pharmaceutical importer based in South Africa with a total trade value of $11.1M across 7 products in 5 therapeutic categories. Based on 236 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Macleods Pharmaceuticals SA sources from 1 verified Indian supplier, with Macleods Pharmaceuticals Limited accounting for 100.0% of imports.

Macleods Pharmaceuticals SA — Import Portfolio & Supplier Network

Macleods Pharmaceuticals SA import network — 7 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Macleods Pharmaceuticals SA?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Macleods Pharmaceuticals Limited	$27.3M	1,315	100.0%

Macleods Pharmaceuticals SA sources from 1 verified Indian supplier across 765 distinct formulations. The sourcing is highly concentrated — Macleods Pharmaceuticals Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
Drugs and pharmaceuticals harmless	$3.2M	148
Rifampicin 150MG+isoniazid	$583.9K	15
Medicines. rifampicin 150MG+isoniazid	$559.6K	12
Medicines. rifampicin 150MG +	$422.4K	12
Efavirenz 600MG + emtricitabine 200MG	$389.8K	8
Hydrocortisone sodium succinate injection 100 MG Each vial containing hydrocortisone sodium succinate 134 MG	$251.4K	6
Macleods hydrocortisone injection 100MG	$200.0K	4
Drugs and pharmaceuticals harmless medicines terizidone capsules 250 MG	$200.0K	4
Medicines. rifampicin 300MG+isoniazid	$150.0K	3
Elturin 600 (linezolid) 1 x10s	$150.0K	3
Pravlex (tamsulosin) hci sr capsules	$150.0K	3
Drugs and pharmaceuticals harmless medicines rifampicin and isoniazid tablets 300 MG/150 MG	$150.0K	3
Syromak (dolutegravir sodium dispersibletablets 10 MG) 1x30s (121126 pac	$150.0K	3
Drugs and pharmaceuticals harmless medicines rifampicin and isoniazid tablets (300 MG/150 MG	$150.0K	3
Triolar tablets (efavirenz 600MG emtricitabine 200MG & tenofovir 300MG tabs 1x30s (27136 pac	$148.9K	3

Import Portfolio — Top 7 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Rifampicin	Advanced Antibiotics	$3.3M	66	0.2%	15
2	Isoniazid	Tuberculosis Medications	$3.2M	64	0.1%	19
3	Efavirenz	Antivirals	$1.3M	25	2.1%	2
4	Tenofovir	Antiviral & HIV Medications	$1.1M	22	0.0%	11
5	Hydrocortisone	Corticosteroids	$1.1M	36	1.2%	10
6	Emtricitabine	Antiviral & HIV Medications	$900.0K	18	0.8%	2
7	Linezolid	Advanced Antibiotics	$250.0K	5	0.7%	10

Macleods Pharmaceuticals SA imports 7 pharmaceutical products across 5 categories into South Africa totaling $11.1M.

Macleods Pharmaceuticals SA — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Macleods Pharmaceuticals SA is a subsidiary of Macleods Pharmaceuticals Limited, a leading Indian pharmaceutical company established in 1989. The South African arm commenced operations in 2006, focusing on providing essential medicines such as anti-TB and ARV products to meet local healthcare needs. Headquartered in Alberton, Gauteng, Macleods Pharmaceuticals SA has expanded its portfolio to include over 90 products registered with the South African Health Products Regulatory Authority (SAHPRA) as of September 2022. (macleodshealth.co.za)

The company operates as a pharmaceutical importer and distributor, sourcing finished pharmaceutical formulations from its parent company in India. These products are then distributed across South Africa, serving both public and private healthcare sectors. Macleods Pharmaceuticals SA's commitment to quality is evident in its adherence to international manufacturing standards, with facilities inspected by regulatory bodies such as the US FDA, WHO Geneva, UK MHRA, and ANVISA. (macleodshealth.co.za)

2Distribution Network

Macleods Pharmaceuticals SA's distribution network is centralized at its headquarters in Alberton, Gauteng. The company imports finished pharmaceutical formulations from its parent company in India, which are then distributed throughout South Africa. While specific warehouse locations and logistics capabilities are not publicly detailed, the company's extensive product portfolio and participation in national tenders suggest a well-established distribution infrastructure capable of meeting the demands of both public and private healthcare sectors. (macleodshealth.co.za)

3Industry Role

In South Africa's pharmaceutical supply chain, Macleods Pharmaceuticals SA functions primarily as an importer and distributor of finished pharmaceutical formulations. By sourcing products from its parent company in India, the subsidiary plays a crucial role in enhancing the availability of essential medicines, including anti-TB and ARV treatments, within the South African market. The company's active participation in national tenders further underscores its significant position in the supply chain.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Macleods Pharmaceuticals SA

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Macleods Pharmaceuticals SA's sourcing strategy is highly concentrated, with all imports originating from its parent company, Macleods Pharmaceuticals Limited in India. This single-source dependency indicates a strategic choice to maintain consistent product quality and supply chain efficiency. The substantial volume of imports—totaling $11.1 million USD across 236 shipments—reflects a stable and robust relationship between the subsidiary and its parent company. However, this concentration also exposes the company to potential risks associated with supply chain disruptions in India. The high volume and frequency of shipments suggest effective logistical coordination and a reliable supply chain.

2Supply Chain Resilience

Macleods Pharmaceuticals SA's supply chain resilience is closely tied to its parent company's operations in India. The company's single-source dependency on Macleods Pharmaceuticals Limited indicates a streamlined supply chain but also highlights potential vulnerabilities to disruptions in India. The extensive product portfolio, with 765 unique formulations, suggests a diversified range of products, which may mitigate some risks. However, the lack of publicly available information on backup suppliers and alternative sourcing strategies indicates a need for further assessment to enhance supply chain resilience.

Importing Pharmaceuticals into South Africa — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for South Africa

1Regulatory Authority & Framework

In South Africa, the South African Health Products Regulatory Authority (SAHPRA) is the primary regulatory body overseeing the registration and regulation of pharmaceutical products. Key legislation governing pharmaceutical imports includes the Medicines and Related Substances Act, which outlines requirements for the importation, registration, and distribution of medicines. The marketing authorization pathway for Indian generics involves obtaining SAHPRA registration, which requires submission of comprehensive documentation, including evidence of bioequivalence, manufacturing practices, and product quality. Compliance with these regulatory standards is essential for market entry and continued operation within South Africa.

2Import Licensing & GMP

Import licensing requirements in South Africa mandate that pharmaceutical manufacturers or wholesalers be licensed to import and distribute medicines. This includes compliance with Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP) as outlined by SAHPRA. International certifications such as EU GMP, WHO GMP, and PIC/S are recognized and can facilitate the importation process. Additionally, wholesale distribution authorization from SAHPRA is required to operate legally within the country. Adherence to these standards ensures product quality and safety for consumers.

Macleods Pharmaceuticals SA — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Macleods Pharmaceuticals SA's product strategy focuses on essential therapeutic areas, including anti-TB, ARV, and antiviral medications. This focus aligns with the significant public health needs in South Africa, where diseases such as tuberculosis and HIV/AIDS are prevalent. The company's commitment to quality and affordability drives its product offerings, ensuring that critical medications are accessible to a broad patient base. The introduction of innovative products, such as the first-to-market generic ziprasidone, demonstrates Macleods' dedication to meeting diverse medical needs. (india.org.za)

2Sourcing Profile

Macleods Pharmaceuticals SA's sourcing strategy is centered on importing finished pharmaceutical formulations from its parent company, Macleods Pharmaceuticals Limited in India. This approach ensures consistent product quality and leverages the manufacturing capabilities of the parent company. The extensive product portfolio, with 765 unique formulations, indicates a comprehensive approach to meeting various therapeutic needs within the South African market. India's established reputation for pharmaceutical manufacturing and its compliance with international standards make it a strategic sourcing partner for Macleods Pharmaceuticals SA.

3Market Positioning

Seller's Guide — How to Become a Supplier to Macleods Pharmaceuticals SA

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

While Macleods Pharmaceuticals SA's strong relationship with its parent company in India presents challenges for new Indian suppliers seeking to enter the South African market, opportunities may exist in niche therapeutic areas or through value-added services that complement the existing product offerings. Indian exporters can explore these avenues by understanding the specific needs of the South African market and aligning their products and services accordingly. Engaging in strategic partnerships or joint ventures with Macleods Pharmaceuticals SA may also provide a pathway for market entry.

2Requirements & Qualifications

Indian exporters aiming to supply Macleods Pharmaceuticals SA and the South African market must ensure compliance with SAHPRA's regulatory requirements, including obtaining necessary import licenses and adhering to GMP and GDP standards. International certifications such as EU GMP, WHO GMP, and PIC/S are recognized and can facilitate the importation process. Additionally, products must meet SAHPRA's quality and labeling standards, including batch testing, stability studies, and appropriate labeling in English. Ensuring these qualifications will enhance the likelihood of successful market entry.

How to Approach

Frequently Asked Questions — Macleods Pharmaceuticals SA

What products does Macleods Pharmaceuticals SA import from India?

Macleods Pharmaceuticals SA imports 7 pharmaceutical products across 5 categories. Top imports: Rifampicin ($3.3M), Isoniazid ($3.2M), Efavirenz ($1.3M), Tenofovir ($1.1M), Hydrocortisone ($1.1M).

Who supplies pharmaceuticals to Macleods Pharmaceuticals SA from India?

Macleods Pharmaceuticals SA sources from 1 verified Indian suppliers. The primary supplier is Macleods Pharmaceuticals Limited (100.0% of imports, $27.3M).

What is Macleods Pharmaceuticals SA's total pharmaceutical import value?

Macleods Pharmaceuticals SA's total pharmaceutical import value from India is $11.1M, based on 236 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Macleods Pharmaceuticals SA focus on?

Macleods Pharmaceuticals SA imports across 5 categories. The largest: Advanced Antibiotics (32.0%), Tuberculosis Medications (28.9%), Antiviral & HIV Medications (18.0%).

Get Full Macleods Pharmaceuticals SA Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.